Table 1. Patient data and demographics.
| sex | age | type | therapy | EDSS score | Disease duration (y) | GM SUVt | WM SUVt | WM/GM ratio | |
| MS 1 | F | 47 | RR | IFNβ, MTX | 7 | 10.3 | 1.0494 | 0.9415 | 0.8972 |
| MS 2 | F | 45 | RR | IFNβ | 2 | 6.8 | 1.1069 | 1.0529 | 0.9512 |
| MS 3 | F | 48 | RR | IFNβ | 1 | 5.7 | 1.0282 | 0.8874 | 0.8631 |
| MS 4 | F | 53 | RR | IFNβ | 2.5 | 7.4 | 1.0837 | 0.9434 | 0.8705 |
| MS 5 | F | 34 | RR | - | 4 | 3.3 | 0.9633 | 0.8244 | 0.8558 |
| MS 6 | F | 49 | RR | - | 1 | 1.4 | 1.0336 | 0.9044 | 0.8750 |
| HV 1 | F | 54 | 0.9149 | 0.7320 | 0.8001 | ||||
| HV 2 | F | 61 | 0.9671 | 0.8121 | 0.8397 | ||||
| HV 3 | F | 41 | 0.9518 | 0.7789 | 0.8183 | ||||
| HV 4 | F | 67 | 0.9341 | 0.7946 | 0.8507 | ||||
| HV 5 | F | 62 | 0.9449 | 0.8021 | 0.8489 | ||||
| HV 6 | F | 63 | 0.9758 | 0.8096 | 0.8297 |
MS = multiple sclerosis, HV = healthy volunteer, RR = relapsing-remitting multiple sclerosis, IFNβ = interferon beta treatment, MTX = Mitoxantrone, EDSS = Expanded Disability Status Scale, SUV = standardized uptake value.